EGLN3 and osteosarcoma: The phenotypic alterations observed in PHD3-deficient osteosarcoma are in line with the hypothesis that PHD3 limits PDGF-C expression in tumor cells, inhibits the recruitment of perivascular cells, and restricts tumor cell proliferation in a tumor cell non-autonomous fashion.